RACHEL JACOB: Open Payments
NPI 1336680461 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,312 in 167 payments from 25 companies in 2025. Trend: 2023 $2,167 · 2024 $2,711 · 2025 $3,312
Food & beverage: $3,233Education: $79
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $426 |
| Grifols USA, LLC | 46 | $376 |
| GlaxoSmithKline, LLC. | 23 | $357 |
| Regeneron Healthcare Solutions, Inc. | 9 | $269 |
| GENZYME CORPORATION | 9 | $247 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $223 |
| Verona Pharma, Inc. | 6 | $193 |
| Viatris Specialty LLC | 6 | $161 |
| Insmed, Inc. | 10 | $159 |
| Inspire Medical Systems, Inc. | 4 | $153 |
Products named: DUPIXENT, Prolastin-C Liquid, BREZTRI, OFEV, Ohtuvayre, TRELEGY ELLIPTA, NUCALA, YUPELRI.
Industry payments across AZ — which companies pay providers there.
